Quarterly report pursuant to Section 13 or 15(d)

EARNINGS PER SHARE (Details - Diluted Shares)

v3.24.1
EARNINGS PER SHARE (Details - Diluted Shares) - shares
9 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 25,279,694 10,172,783
Equity Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 779,794 281,936
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 18,570,847 9,890,847
Preferred Stock Including Additional Paid in Capital [Member] | Series B Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 5,929,053 0